Condition

Psoriasis Vulgaris clinical trials and research

• 9Clinical trials
• 6Countries

Newest Psoriasis Vulgaris clinical trials

All recruiting trials (9)

• HRS-4139 safety and pharmacology in healthy adults

  This early-phase study tests a single dose of HRS-4139 to see if it is safe and how the body handles it in healthy adults aged 18–55.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Changsha, Hunan · NCT07802964

• Total Coumarin botanical cream for psoriasis vulgaris

  This trial will try a botanical Total Coumarin cream applied twice daily for 8 weeks to see if it helps adults with mild to moderate psoriasis.

  Recruiting Phase 3 Psoriasis Research Institute of Guangzhou · New York, New York · NCT07426120

• Topical diacerein in plaque psoriasis (adult) explores if a cream helps skin improve

  This trial tests whether applying a topical diacerein cream twice daily for 8 weeks helps adults with mild-to-moderate psoriasis vulgaris improve symptoms more than a placebo.

  Recruiting Phase 4 Cairo University · Cairo · NCT07352306

• Vaspin gene changes and blood vaspin levels in people with psoriasis

  This test will see if specific vaspin gene variants are linked to blood vaspin levels in people with psoriasis.

  Recruiting Aswan University · Aswān · NCT07320872

• Optimizing biologic dosing for psoriasis treatment

  This study is testing if a new way of adjusting psoriasis medication based on blood tests can work just as well as the usual method over 18 months.

  Recruiting at 10 sites Phase 4 University Hospital, Ghent · Bruges and 14 other locations · NCT06398106

• Treatment of psoriasis with deucravacitinib

  This study is testing how well a new medication called deucravacitinib can change immune cell behavior in people with moderate to severe psoriasis.

  Recruiting Phase 4 University of California, San Francisco · San Francisco, California · NCT05858645

• Shuiniujiao Dihuang Decoction With Variation for Psoriasis

  A 12-week study tests whether the Chinese medicine formula Shuiniujiao Dihuang Decoction with Variation can help people with mild to moderate plaque psoriasis compared with placebo.

  Recruiting Phase 2 Chinese University of Hong Kong · Hong Kong · NCT05815797

• Assessing immune response in psoriasis patients treated with Tildrakizumab

  This study tests how the medication Tildrakizumab affects the immune system in people with moderate to severe psoriasis by looking at their skin and blood before and after treatment.

  Recruiting Phase 4 University of California, San Francisco · San Francisco, California · NCT05390515

• Investigating heart disease risk factors in psoriasis patients

  This study is trying to see if certain heart-related markers can help predict heart disease risk in people with psoriasis.

  Recruiting Herlev and Gentofte Hospital · Hellerup, Copenhagne · NCT04950218

Related topics

Quick answers

How many Psoriasis Vulgaris clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (3 trials), Egypt (2 trials), Denmark (1 trial), China (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 4, Phase 1: 1, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →